THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 48 filers reported holding THESEUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $991,695 | -71.1% | 368,660 | +0.3% | 0.00% | – |
| Q2 2023 | $3,428,924 | +30.1% | 367,516 | +23.8% | 0.00% | – |
| Q1 2023 | $2,636,152 | -2.5% | 296,864 | -45.3% | 0.00% | – |
| Q4 2022 | $2,703,950 | +87.8% | 542,962 | +118.7% | 0.00% | – |
| Q3 2022 | $1,440,000 | +11.4% | 248,281 | +6.2% | 0.00% | – |
| Q2 2022 | $1,293,000 | -38.6% | 233,893 | +28.0% | 0.00% | – |
| Q1 2022 | $2,106,000 | +31.0% | 182,661 | +44.1% | 0.00% | – |
| Q4 2021 | $1,608,000 | – | 126,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 3,212,732 | $40,737,000 | 10.01% |
| Lynx1 Capital Management LP | 409,358 | $5,191,000 | 4.53% |
| Foresite Capital Opportunity Management V, LLC | 468,820 | $5,945,000 | 3.99% |
| Orbimed Advisors | 16,838,668 | $213,514,000 | 2.74% |
| Nextech Invest Ltd. | 611,310 | $7,751,000 | 2.04% |
| Omega Fund Management, LLC | 711,479 | $9,022,000 | 1.28% |
| Boxer Capital, LLC | 892,057 | $11,311,000 | 0.44% |
| DAFNA Capital Management LLC | 97,500 | $1,236,000 | 0.31% |
| Rock Springs Capital Management LP | 437,329 | $5,545,000 | 0.13% |
| Woodline Partners LP | 250,000 | $3,170,000 | 0.04% |